James H Tabibian

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Sirolimus based immunosuppression is associated with need for early repeat therapeutic ERCP in liver transplant patients with anastomotic biliary stricture
    James H Tabibian
    Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD U S A
    Ann Hepatol 12:563-9. 2013
  2. doi Technetium-labeled erythrocyte scintigraphy in acute gastrointestinal bleeding
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA
    Int J Colorectal Dis 28:1099-105. 2013
  3. doi Primary sclerosing cholangitis: a review and update on therapeutic developments
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Expert Rev Gastroenterol Hepatol 7:103-14. 2013
  4. ncbi Sirolimus may be associated with early recurrence of biliary obstruction in liver transplant patients undergoing endoscopic stenting of biliary strictures
    James H Tabibian
    Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Ann Hepatol 10:270-6. 2011
  5. ncbi Risk factors for early repeat ERCP in liver transplantation patients with anastomotic biliary stricture
    James H Tabibian
    Division of Gastroenterology, Hepatology, and Transplant Hepatology, Johns Hopkins School of Medicine, Baltimore, MD, USA Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Ann Hepatol 14:340-7. 2015
  6. pmc Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN
    Hepatology 63:185-96. 2016
  7. doi Weekend Admission for Acute Cholangitis Does Not Adversely Impact Clinical or Endoscopic Outcomes
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA
    Dig Dis Sci 61:53-61. 2016
  8. pmc Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR)
    Christy E Trussoni
    Division of Gastroenterology and Hepatology, and the Mayo Clinic Center for Cell Signaling in Gastroenterology, Mayo Clinic, Rochester, Minnesota, 55905, United States of America
    PLoS ONE 10:e0125793. 2015
  9. doi  Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis
    Moira Hilscher
    Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
    Ann Hepatol 15:246-53. 2016
  10. pmc Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA Center for Clinical and Translational Sciences, Mayo Graduate School, Rochester, MN, USA
    Ann Hepatol 13:384-9. 2014

Collaborators

Detail Information

Publications17

  1. ncbi Sirolimus based immunosuppression is associated with need for early repeat therapeutic ERCP in liver transplant patients with anastomotic biliary stricture
    James H Tabibian
    Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD U S A
    Ann Hepatol 12:563-9. 2013
    ..We therefore investigated whether sirolimus use is associated with need for early or emergent repeat therapeutic endoscopic retrograde cholangiography (ERC) in LT patients with anastomotic biliary stricture (ABS)...
  2. doi Technetium-labeled erythrocyte scintigraphy in acute gastrointestinal bleeding
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA
    Int J Colorectal Dis 28:1099-105. 2013
    ..We evaluated our recent experience with and the clinical outcomes of the TRBC scan in patients presenting with acute GI bleeding...
  3. doi Primary sclerosing cholangitis: a review and update on therapeutic developments
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Expert Rev Gastroenterol Hepatol 7:103-14. 2013
    ..The authors herein provide a review of previously tested pharmacologic agents, discuss emerging fundamental concepts and present viewpoints regarding how identifying therapies for PSC may evolve over the next several years...
  4. ncbi Sirolimus may be associated with early recurrence of biliary obstruction in liver transplant patients undergoing endoscopic stenting of biliary strictures
    James H Tabibian
    Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    Ann Hepatol 10:270-6. 2011
    ..We evaluated the relationship between prednisone or sirolimus use and early recurrence of biliary obstruction given their negative effects on collagen production and cholangiocyte regeneration...
  5. ncbi Risk factors for early repeat ERCP in liver transplantation patients with anastomotic biliary stricture
    James H Tabibian
    Division of Gastroenterology, Hepatology, and Transplant Hepatology, Johns Hopkins School of Medicine, Baltimore, MD, USA Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Ann Hepatol 14:340-7. 2015
    ..e. emergent or unplanned) repeat endoscopic retrograde cholangiopancreatographies (ER-ERCPs). Our aim was to determine clinical, operative, and endoscopic predictors of ER-ERCP in patients with ABS...
  6. pmc Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN
    Hepatology 63:185-96. 2016
    ..01) and were confirmed by hepatic morphometry, hydroxyproline assay, and IFM. Cholangiocyte senescence was significantly increased in GF mdr2(-/-) mice and abrogated in vitro by ursodeoxycholic acid (UDCA) treatment...
  7. doi Weekend Admission for Acute Cholangitis Does Not Adversely Impact Clinical or Endoscopic Outcomes
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA
    Dig Dis Sci 61:53-61. 2016
    ..Acute cholangitis (AC) requires prompt diagnosis and treatment for optimal management...
  8. pmc Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR)
    Christy E Trussoni
    Division of Gastroenterology and Hepatology, and the Mayo Clinic Center for Cell Signaling in Gastroenterology, Mayo Clinic, Rochester, Minnesota, 55905, United States of America
    PLoS ONE 10:e0125793. 2015
    ..These findings have implications not only for revealing the signaling potential of TLRs, but also implicate EGFR as an integral component of cholangiocyte TLR-induced proinflammatory processes. ..
  9. doi  Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis
    Moira Hilscher
    Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
    Ann Hepatol 15:246-53. 2016
    ..However, this association remains poorly understood. Therefore, the aim of this study was to investigate the prognostic significance and clinical correlates of alkaline phosphatase normalization in primary sclerosing cholangitis...
  10. pmc Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA Center for Clinical and Translational Sciences, Mayo Graduate School, Rochester, MN, USA
    Ann Hepatol 13:384-9. 2014
    ..Our aim in this study was to determine whether IgE levels predict time to CCA, liver transplantation, or death in a Western (USA-based) cohort of PSC patients...
  11. pmc Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?
    James H Tabibian
    Department of Medicine, Johns Hopkins Hospital, Baltimore, Maryland, USA
    J Gastroenterol Hepatol 26:501-9. 2011
    ..We explored clinical, laboratory, and histological features of NAFLD as well as risk factors for histologically advanced disease among under-represented ethno-racial groups...
  12. doi Primary biliary cirrhosis: safety and benefits of established and emerging therapies
    James H Tabibian
    a 1 Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, MN, USA
    Expert Opin Drug Saf 14:1435-44. 2015
    ..Patients who are non-responders to UDCA or have highly symptomatic disease (e.g., intractable pruritus) are thus in critical need of novel therapeutic approaches, which are both safe and effective...
  13. pmc Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitis
    John E Eaton
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Am J Gastroenterol 110:299-309. 2015
    ..Therefore, our aim is to determine whether patients with MFP are more likely to manifest CCA compared with patients with other chromosomal abnormalities including UFP and other FISH subtypes...
  14. pmc Characterization of cultured cholangiocytes isolated from livers of patients with primary sclerosing cholangitis
    James H Tabibian
    1 Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA 2 Center for Cell Signaling in Gastroenterology, Mayo Clinic College of Medicine, Rochester, MN, USA
    Lab Invest 94:1126-33. 2014
    ..Isolated PSC cholangiocytes exhibit a phenotype that may reflect their in vivo contribution to disease and serve as a vital tool for in vitro investigation of biliary pathobiology and identification of new therapeutic targets in PSC...
  15. pmc Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Scand J Gastroenterol 49:901-8. 2014
    ....
  16. pmc Role of the microbiota and antibiotics in primary sclerosing cholangitis
    James H Tabibian
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Sreet SW, Rochester, MN 55905, USA
    Biomed Res Int 2013:389537. 2013
    ....
  17. doi Use of a single-balloon enteroscope compared with variable-stiffness colonoscopes for endoscopic retrograde cholangiography in liver transplant patients with Roux-en-Y biliary anastomosis
    Nabeel Azeem
    Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Gastrointest Endosc 77:568-77. 2013
    ..Endoscopic retrograde cholangiography (ERC) is technically challenging in liver transplant patients with Roux-en-Y biliary anastomosis. The optimal endoscope for such cases remains unknown...